This #OvarianCancerAwarenessMonth, #CCTG continues the research toward new and better treatment options for #ovariancancer patients.
#SolvingCancerTogether #CancerResearch
#SolvingCancerTogether #CancerResearch
September 10, 2025 at 2:32 PM
This #OvarianCancerAwarenessMonth, #CCTG continues the research toward new and better treatment options for #ovariancancer patients.
#SolvingCancerTogether #CancerResearch
#SolvingCancerTogether #CancerResearch
Today is #InternationalPrideDay. Together, we stand for equality and inclusion in all aspects of life, including #cancercare and #research.
#SolvingCancerTogether
#SolvingCancerTogether
June 28, 2025 at 12:01 PM
Today is #InternationalPrideDay. Together, we stand for equality and inclusion in all aspects of life, including #cancercare and #research.
#SolvingCancerTogether
#SolvingCancerTogether
May is #SkinCancerAwareness Month. #CCTG honors all individuals affected by the battle against skin cancer, your courage is a true inspiration. #SolvingCancerTogether
May 21, 2025 at 2:31 PM
May is #SkinCancerAwareness Month. #CCTG honors all individuals affected by the battle against skin cancer, your courage is a true inspiration. #SolvingCancerTogether
This #ColorectalCancerAwarenessMonth, CCTG wants to raises awareness for those affected by #colorectal cancer. Let’s continue to work together to advance #colorectalcancer research. #SolvingCancerTogether
March 5, 2025 at 2:30 PM
This #ColorectalCancerAwarenessMonth, CCTG wants to raises awareness for those affected by #colorectal cancer. Let’s continue to work together to advance #colorectalcancer research. #SolvingCancerTogether
#CCTG’s SKC1 trial has opened in Canada. This study is evaluating whether adding immunotherapy to surgery can improve outcomes for individuals with advanced skin cancer. #SkinCancer #SolvingCancerTogether
buff.ly/51M10Dh
buff.ly/51M10Dh
July 21, 2025 at 12:04 PM
#CCTG’s SKC1 trial has opened in Canada. This study is evaluating whether adding immunotherapy to surgery can improve outcomes for individuals with advanced skin cancer. #SkinCancer #SolvingCancerTogether
buff.ly/51M10Dh
buff.ly/51M10Dh
Today is #WorldKidneyCancerDay. #CCTG is committed to advancing kidney cancer research through clinical trials that improve treatment and patient outcomes. Our ongoing work helps shape evidence-based care for patients across Canada. #SolvingCancerTogether
June 19, 2025 at 12:02 PM
Today is #WorldKidneyCancerDay. #CCTG is committed to advancing kidney cancer research through clinical trials that improve treatment and patient outcomes. Our ongoing work helps shape evidence-based care for patients across Canada. #SolvingCancerTogether
#SolvingCancerTogether #CCTG - co-leads Dr Christopher Booth and Dr Kerry Courneya
Here’s why exercise is so important if you’re a #cancer survivor. While not everyone with cancer will be able to work out, this is what experts recommend you try, by Caren Chesler www.washingtonpost.com/wellness/202... via @washingtonpost.com
Here’s why exercise is so important if you’re a cancer survivor
While not everyone with cancer will be able to work out, here’s what experts recommend you try.
www.washingtonpost.com
June 12, 2025 at 2:21 PM
#SolvingCancerTogether #CCTG - co-leads Dr Christopher Booth and Dr Kerry Courneya
#CCTG Trials in Development quarterly update is now available. These are planned studies advancing cancer research across multiple disease sites. Keep an eye out for updates as new trials open for enrollment!
#SolvingCancerTogether #CancerResearch #ClinicalTrials
buff.ly/6VDElKO
#SolvingCancerTogether #CancerResearch #ClinicalTrials
buff.ly/6VDElKO
July 24, 2025 at 12:01 PM
#CCTG Trials in Development quarterly update is now available. These are planned studies advancing cancer research across multiple disease sites. Keep an eye out for updates as new trials open for enrollment!
#SolvingCancerTogether #CancerResearch #ClinicalTrials
buff.ly/6VDElKO
#SolvingCancerTogether #CancerResearch #ClinicalTrials
buff.ly/6VDElKO
#CCTG spotlights the MAC27 trial on #WorldCancerDay. The study is investigating if adding a new drug to a commonly used treatment is better at preventing this type of #breast #cancer from returning. #SolvingCancerTogether
https://buff.ly/3U2gbP5
https://buff.ly/3U2gbP5
February 4, 2025 at 5:00 PM
#CCTG spotlights the MAC27 trial on #WorldCancerDay. The study is investigating if adding a new drug to a commonly used treatment is better at preventing this type of #breast #cancer from returning. #SolvingCancerTogether
https://buff.ly/3U2gbP5
https://buff.ly/3U2gbP5
Today is International Childhood Cancer Day. CCTG supports the children and their families affected by cancer #ChildhoodCancer #SolvingCancerTogether
February 15, 2025 at 3:00 PM
Today is International Childhood Cancer Day. CCTG supports the children and their families affected by cancer #ChildhoodCancer #SolvingCancerTogether
March is #MyelomaAwarenessMonth. CCTG shines light on the strength and courage of everyone impacted by Myeloma. Join us in raising awareness and showing our support this month, and every month. #SolvingCancerTogether
March 25, 2025 at 8:00 PM
March is #MyelomaAwarenessMonth. CCTG shines light on the strength and courage of everyone impacted by Myeloma. Join us in raising awareness and showing our support this month, and every month. #SolvingCancerTogether
On #GlioblastomaAwarenessDay , #CCTG honors those affected by brain cancer and recognizes the ongoing need for research, innovation, and support in the fight against this aggressive form of #BrainCancer
#SolvingCancerTogether
#SolvingCancerTogether
July 17, 2025 at 12:03 PM
On #GlioblastomaAwarenessDay , #CCTG honors those affected by brain cancer and recognizes the ongoing need for research, innovation, and support in the fight against this aggressive form of #BrainCancer
#SolvingCancerTogether
#SolvingCancerTogether
During #BloodCancerAwarenessMonth, we’re spotlighting HD12, a phase III #CCTG clinical trial evaluating a new targeted therapy combination against the current standard for early-stage #Hodgkinlymphoma.
#BloodCancerResearch #SolvingCancerTogether
Trial page -> buff.ly/n304NuP
#BloodCancerResearch #SolvingCancerTogether
Trial page -> buff.ly/n304NuP
September 23, 2025 at 11:30 AM
During #BloodCancerAwarenessMonth, we’re spotlighting HD12, a phase III #CCTG clinical trial evaluating a new targeted therapy combination against the current standard for early-stage #Hodgkinlymphoma.
#BloodCancerResearch #SolvingCancerTogether
Trial page -> buff.ly/n304NuP
#BloodCancerResearch #SolvingCancerTogether
Trial page -> buff.ly/n304NuP
Today is #SarcomaAwarenessMonth , a reminder of the importance of continued research for this rare cancer. #CCTG remains committed to advancing clinical trials that help improve outcomes for #sarcoma patients. #SolvingCancerTogether
July 3, 2025 at 6:01 PM
Today is #SarcomaAwarenessMonth , a reminder of the importance of continued research for this rare cancer. #CCTG remains committed to advancing clinical trials that help improve outcomes for #sarcoma patients. #SolvingCancerTogether
Today is #WorldCancerDay! A closer look at the #CCTG HD11 trial that compares a combination of new agents to the standard treatment for #Hodgkin #Lymphoma patients. #SolvingCancerTogether https://buff.ly/42MlyaB
February 4, 2025 at 2:00 PM
Today is #WorldCancerDay! A closer look at the #CCTG HD11 trial that compares a combination of new agents to the standard treatment for #Hodgkin #Lymphoma patients. #SolvingCancerTogether https://buff.ly/42MlyaB
As part of #VolunteerWeek, #CCTG extends a heartfelt thank you to the members of our Patient Representative Committee. Your insight, commitment, and dedication are critical to integrating the patient perspective into our national research agenda. #SolvingCancerTogether
April 29, 2025 at 2:33 PM
As part of #VolunteerWeek, #CCTG extends a heartfelt thank you to the members of our Patient Representative Committee. Your insight, commitment, and dedication are critical to integrating the patient perspective into our national research agenda. #SolvingCancerTogether
In light of #BrainCancerAwareness Month, #CCTG honors the strength and courage of those affected by the battle against brain cancer. We are committed to continuing to advance research and treatment for patients. #SolvingCancerTogether
May 12, 2025 at 2:31 PM
In light of #BrainCancerAwareness Month, #CCTG honors the strength and courage of those affected by the battle against brain cancer. We are committed to continuing to advance research and treatment for patients. #SolvingCancerTogether
#CCTG is featuring the HN13 clinical trial during #HeadandNeckCancer Awareness Month, comparing the effects on patients and their cancer of a new type of radiation treatment compared with standard radiation therapy. #SolvingCancerTogether
buff.ly/3KGrStm
buff.ly/3KGrStm
April 15, 2025 at 2:31 PM
#CCTG is featuring the HN13 clinical trial during #HeadandNeckCancer Awareness Month, comparing the effects on patients and their cancer of a new type of radiation treatment compared with standard radiation therapy. #SolvingCancerTogether
buff.ly/3KGrStm
buff.ly/3KGrStm
Melanoma clinical trial ME17 is officially open for enrollment in Canada. The study will compare immunotherapy alone with adding FMT treatment to the immunotherapy to improve outcomes. #SolvingCancerTogether
Learn more: https://buff.ly/4h6eeL0
Learn more: https://buff.ly/4h6eeL0
January 22, 2025 at 7:45 PM
Melanoma clinical trial ME17 is officially open for enrollment in Canada. The study will compare immunotherapy alone with adding FMT treatment to the immunotherapy to improve outcomes. #SolvingCancerTogether
Learn more: https://buff.ly/4h6eeL0
Learn more: https://buff.ly/4h6eeL0
#CCTG trial spotlight for #GynecologicCancerAwarenessMonth: EN10 is exploring if some people with low-risk endometrial cancer can safely receive less treatment after surgery, reducing side effects without affecting outcomes.
#EndometrialCancer #SolvingCancerTogether
Trial Info -> buff.ly/HNFFDOt
#EndometrialCancer #SolvingCancerTogether
Trial Info -> buff.ly/HNFFDOt
September 26, 2025 at 11:15 AM
#CCTG trial spotlight for #GynecologicCancerAwarenessMonth: EN10 is exploring if some people with low-risk endometrial cancer can safely receive less treatment after surgery, reducing side effects without affecting outcomes.
#EndometrialCancer #SolvingCancerTogether
Trial Info -> buff.ly/HNFFDOt
#EndometrialCancer #SolvingCancerTogether
Trial Info -> buff.ly/HNFFDOt
#CCTG spotlights the BRC8 clinical trial recognizing #WorldLungCancerDay: Researchers are investigating if regular MRI surveillance can be as effective as MRI with preventive brain radiation for people with small cell #lungcancer.
#SolvingCancerTogether
Trial page -> buff.ly/mPsQZyN
#SolvingCancerTogether
Trial page -> buff.ly/mPsQZyN
August 5, 2025 at 1:15 PM
#CCTG spotlights the BRC8 clinical trial recognizing #WorldLungCancerDay: Researchers are investigating if regular MRI surveillance can be as effective as MRI with preventive brain radiation for people with small cell #lungcancer.
#SolvingCancerTogether
Trial page -> buff.ly/mPsQZyN
#SolvingCancerTogether
Trial page -> buff.ly/mPsQZyN
We’re excited to welcome Lesley Beaton, the #CCTG #Gastrointestinal Patient Representative. Lesley brings a unique combination of scientific expertise and lived experience to her role, advocating for trials that are clear, accessible, and patient-informed. #SolvingCancerTogether #PatientsAsPartners
July 9, 2025 at 12:04 PM
We’re excited to welcome Lesley Beaton, the #CCTG #Gastrointestinal Patient Representative. Lesley brings a unique combination of scientific expertise and lived experience to her role, advocating for trials that are clear, accessible, and patient-informed. #SolvingCancerTogether #PatientsAsPartners
The #CCTG SR.8 HARMONY trial has received nearly $1.5M in #CIHR funding. The Canadian-led phase III study that aims to find a new therapy for high-risk soft-tissue #sarcoma using #immunotherapy and new #radiation approaches.
#SarcomaResearch #SolvingCancerTogether @cancersociety.bsky.social
#SarcomaResearch #SolvingCancerTogether @cancersociety.bsky.social
August 12, 2025 at 12:01 PM
The #CCTG SR.8 HARMONY trial has received nearly $1.5M in #CIHR funding. The Canadian-led phase III study that aims to find a new therapy for high-risk soft-tissue #sarcoma using #immunotherapy and new #radiation approaches.
#SarcomaResearch #SolvingCancerTogether @cancersociety.bsky.social
#SarcomaResearch #SolvingCancerTogether @cancersociety.bsky.social
The #CCTG ALC8 trial has opened, testing the effects of novel therapeutics for newly diagnosed, untreated acute myeloid leukemia #AML patients. This trial is part of the #myeloMATCH precision medicine protocol for #AML #MDS patients. #SolvingCancerTogether
https://buff.ly/419yN3S
https://buff.ly/419yN3S
February 12, 2025 at 4:07 PM
The #CCTG ALC8 trial has opened, testing the effects of novel therapeutics for newly diagnosed, untreated acute myeloid leukemia #AML patients. This trial is part of the #myeloMATCH precision medicine protocol for #AML #MDS patients. #SolvingCancerTogether
https://buff.ly/419yN3S
https://buff.ly/419yN3S
On #WorldCancerDay, a closer look at the #CCTG HN13 head & neck cancer trial. The study compares the effects on patients and their cancer of a new type of radiation treatment to improve quality of life. #SolvingCancerTogether https://buff.ly/4hlTQWn
February 4, 2025 at 12:58 PM
On #WorldCancerDay, a closer look at the #CCTG HN13 head & neck cancer trial. The study compares the effects on patients and their cancer of a new type of radiation treatment to improve quality of life. #SolvingCancerTogether https://buff.ly/4hlTQWn